Related Experiment Video
Updated: Nov 29, 2025

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Fatal metabolic stroke in a child with propionic acidemia 11 years post liver transplant
Siyamini Sivananthan1, Nedim Hadžić2, Anil Dhawan2
1Department of Paediatric Inherited Metabolic Disease, Evelina London Children's Hospital, London, UK.
Insights
Propionic acidemia, a metabolic disorder, can lead to serious complications even after liver transplantation. Lifelong monitoring is crucial for patients with propionic acidemia post-transplant to prevent fatal outcomes.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Propionic acidemia is a rare autosomal recessive metabolic disorder.
- Deficiency of propionyl CoA carboxylase leads to metabolic decompensations and neurological injury.
- Current medical therapies offer suboptimal outcomes for propionic acidemia patients.
Abstract:
Propionic acidemia is a rare autosomal recessive inborn error of metabolism caused by a deficiency of propionyl CoA carboxylase which often manifests with frequent metabolic decompensations and risk of neurological injury. Outcomes with medical therapy remain suboptimal. Liver transplantation has been shown to be a therapeutic option for patients and results in a milder phenotype of the disease and partial correction of the enzyme defect. Liver transplantation has been increasingly reported over the last decade and experience in managing these patients is improving. Long-term outcomes are generally good; however, the risk of complications still exists despite transplantation. We report a child who presented with a fatal metabolic stroke 11 years post liver transplant without any biochemical evidence of decompensation. We highlight the need to closely monitor these patients lifelong despite liver transplantation and maintain multidisciplinary working between hepatology and metabolic clinicians.
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

